Related references
Note: Only part of the references are listed.Differential effects of abaloparatide and teriparatide on hip cortical volumetric BMD by DXA-based 3D modeling
R. Winzenrieth et al.
OSTEOPOROSIS INTERNATIONAL (2021)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE EXECUTIVE SUMMARY
Pauline M. Camacho et al.
ENDOCRINE PRACTICE (2020)
Abaloparatide improves cortical geometry and trabecular microarchitecture and increases vertebral and femoral neck strength in a rat model of male osteoporosis
Tatiana Besschetnova et al.
BONE (2019)
Bone-Forming and Antiresorptive Effects of Romosozumab in Postmenopausal Women With Osteoporosis: Bone Histomorphometry and Microcomputed Tomography Analysis After 2 and 12 Months of Treatment
Pascale Chavassieux et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE
R. Eastell et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Response rates for hip, femoral neck, and lumbar spine bone mineral density in patients treated with abaloparatide followed by alendronate: Results from phase 3 ACTIVExtend
Chad L. Deal et al.
BONE REPORTS (2019)
Remodeling- and Modeling-Based Bone Formation With Teriparatide Versus Denosumab: A Longitudinal Analysis From Baseline to 3 Months in the AVA Study
David W. Dempster et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption
N. Doyle et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Effects of Abaloparatide-SC on Fractures and Bone Mineral Density in Subgroups of Postmenopausal Women With Osteoporosis and Varying Baseline Risk Factors
Felicia Cosman et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption
Aurore Varela et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Pharmacological Therapy of Osteoporosis: A Systematic Current Review of Literature
Vito Pavone et al.
FRONTIERS IN PHARMACOLOGY (2017)
Effects of abaloparatide-SC (BA058) on bone histology and histomorphometry: The ACTIVE phase 3 trial
Carolina A. Moreira et al.
BONE (2017)
Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis A Randomized Clinical Trial
Paul D. Miller et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Differential Effects of Teriparatide and Denosumab on Intact PTH and Bone Formation Indices: AVA Osteoporosis Study
David W. Dempster et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Effect of Teriparatide on Bone Formation in the Human Femoral Neck
Felicia Cosman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis
Bente Langdahl et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2016)
Standardized Nomenclature, Symbols, and Units for Bone Histomorphometry: A 2012 Update of the Report of the ASBMR Histomorphometry Nomenclature Committee
David W. Dempster et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Skeletal Histomorphometry in Subjects on Teriparatide or Zoledronic Acid Therapy (SHOTZ) Study: A Randomized Controlled Trial
David W. Dempster et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
PTH(1-84) Administration Reverses Abnormal Bone-Remodeling Dynamics and Structure in Hypoparathyroidism
Mishaela R. Rubin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Effects of intermittent hPTH(1-34) alone and in combination with 1,25(OH)2d3 or risedronate on endosteal bone remodeling in canine cancellous and cortical bone
R.W. Boyce et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Mechanisms of anabolic therapies for osteoporosis
Ernesto Canalis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium
Robert Lindsay et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis
Yanfei L. Ma et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: Early actions of teriparatide
R Lindsay et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Recombinant human parathyroid hormone (1-34) [Teriparatide] improves both cortical and cancellous bone structure
YB Jiang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis:: A paired biopsy study
DW Dempster et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Osteoporosis, genetics and hormones
R Rizzoli et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2001)
Share Paper
